首页> 外文期刊>Journal of Hainan Medical University >Correlation of serum Aβ1-42 content with inflammatory factors and receptors as well as antioxidant enzymes in patients with Parkinson's Disease
【24h】

Correlation of serum Aβ1-42 content with inflammatory factors and receptors as well as antioxidant enzymes in patients with Parkinson's Disease

机译:帕金森氏病患者血清Aβ1-42含量与炎症因子和受体以及抗氧化酶的相关性

获取原文
           

摘要

Objective: To investigate the correlation of serum β-amyloid 1-42 (Aβ1-42) content with inflammatory factors and receptors as well as antioxidant enzymes in patients with Parkinson's Disease. Methods: A total of 48 patients with Parkinson's disease who were treated in this hospital between December 2014 and October 2017 were selected as Parkinson's disease group, and 50 healthy volunteers who received physical examination in this hospital during the same period were selected as normal control group. The differences in serum contents of Aβ1- 42, inflammatory factors and receptors as well as antioxidant enzymes were compared between the two groups, and Pearson test was used to assess the correlation between serum Aβ1-42 content and illness in patients with Parkinson's disease. Results: Serum Aβ1-42 content of Parkinson's disease group was lower than that of normal control group; serum inflammatory factors and receptors IL-2, sIL-2R, IL-6 and sIL-6R contents were higher than those of normal control group; serum antioxidant enzymes SOD, GSH-Px, CAT and TPX contents were lower than those of control group. Pearson test showed that serum Aβ1-42 content of patients with Parkinson's disease was directly correlated with the contents of inflammatory factors and receptors as well as antioxidant enzymes. Conclusions: Serum Aβ1-42 content decreases in patient with Parkinson's disease, and the specific content is directly correlated with the condition of Parkinson's disease, and can be used as an important auxiliary indicator for diagnosis and judgment of Parkinson's disease.
机译:目的:探讨帕金森病患者血清β淀粉样蛋白1-42(Aβ1-42)含量与炎症因子,受体以及抗氧化酶的相关性。方法:选择2014年12月至2017年10月在该医院接受治疗的48例帕金森病患者为帕金森病组,并选择同期在该医院接受身体检查的50名健康志愿者作为正常对照组。 。比较两组患者血清Aβ1-42,炎性因子,受体,抗氧化酶含量的差异,并采用皮尔森检验法评估帕金森病患者血清Aβ1-42含量与疾病的相关性。结果:帕金森病组血清Aβ1-42含量低于正常对照组。血清炎性因子及其受体IL-2,sIL-2R,IL-6和sIL-6R的含量高于正常对照组。血清抗氧化酶SOD,GSH-Px,CAT和TPX含量低于对照组。皮尔逊检验表明,帕金森氏病患者的血清Aβ1-42含量与炎症因子和受体以及抗氧化酶的含量直接相关。结论:帕金森病患者血清Aβ1-42含量降低,其特异性与帕金森病的病情直接相关,可作为诊断和判断帕金森病的重要辅助指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号